Occupational Tuberculosis despite Minimal Nosocomial Contact in a Health Care Worker Undergoing Treatment with a Tumor Necrosis Factor Inhibitor

This publication has 12 references indexed in Scilit:

• Protecting Our Front-liners: Occupational Tuberculosis Prevention Through Infection Control Strategies
  Clinical Infectious Diseases, 2016
• Occupational Tuberculosis in Denmark through 21 Years Analysed by Nationwide Genotyping
  PLOS ONE, 2016
• The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies
  The Journal of Rheumatology, 2015
• Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
  The Lancet Infectious Diseases, 2015
• Adalimumab, Etanercept, Infliximab, and the Risk of Tuberculosis: Data from Clinical Trials, National Registries, and Postmarketing Surveillance
  The Journal of Rheumatology, 2014
• Tuberculosis among Health Care Workers
  Emerging Infectious Diseases, 2011
• The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
  European Respiratory Journal, 2010
• BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF- treatment
  Thorax, 2005
• Are healthcare workers in England and Wales at increased risk of tuberculosis?
  BMJ, 1996
• A New Perspective on John Snow's Communicable Disease Theory
  American Journal of Epidemiology, 1995